![]() Contineum Therapeutics Contineum Therapeutics (formerly known as Pipeline Therapeutics) is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small-molecule therapies for NI&I indications. | Guizhou Sanli Pharmaceutical Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products. | |||
Founding Date | Founding Date 2017 | Founding Date 1995 | Founding Date 1992 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations An Shun Shi, CN HQ | Locations Anderlecht, BE HQ Meudon, FR | Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more |
Employees | Employees 5124% increase | Employees 2,85225% increase | Employees 219 | Employees 5,75359% increase |
Valuation ($) | Valuation ($) 440.1 m | Valuation ($) 796.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.1b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ₹67.2b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods ¥650m (FY, 2024) | Cost of goods N/A | Cost of goods ₹27.6b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit ¥1.5b (FY, 2024) | Gross profit N/A | Gross profit ₹40.7b (FY, 2026) |
Net income | Net income ($60m) (FY, 2025) | Net income ¥279.8m (FY, 2024) | Net income N/A | Net income ₹8.9b (FY, 2026) |
Funding | ||||
Total funding raised | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 90m |
Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products.
View companyEFFIK International is a pharmaceutical laboratory.
View company